Literature DB >> 10816534

Gamma interferon is essential for clearing Mycobacterium genavense infection.

S Ehlers1, E Richter.   

Abstract

Factors determining the in vivo replication of the opportunistic pathogen Mycobacterium genavense are largely unknown. Following intravenous injection of a patient isolate, M. genavense could not be recovered by culture or detected by PCR in the livers or spleens of infected BALB/c mice. In contrast, M. genavense was found to chronically persist and multiply in the livers and spleens of intravenously infected syngeneic gamma-interferon-gene-deficient (GKO) mice as evidenced by acid-fast stains of infected tissues and recovery by both PCR and liquid culture following organ homogenization. In GKO mice, M. genavense elicited a chronic inflammatory response, resulting in marked splenomegaly and extensive lymphadenopathy. Granulomatous lesions in the livers of GKO mice were diffuse, were composed of monocytes, neutrophils, and CD3(+) cells, and were histochemically negative for inducible nitric oxide synthase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816534      PMCID: PMC97665          DOI: 10.1128/IAI.68.6.3720-3723.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Authors:  E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

2.  Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus.

Authors:  C Bogdan; P Kern; E Richter; A Tannapfel; S Rüsch-Gerdes; T Kirchner; W Solbach
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads.

Authors:  S Ehlers; S Kutsch; J Benini; A Cooper; C Hahn; J Gerdes; I Orme; C Martin; E T Rietschel
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Detection and identification of mycobacteria by amplification of rRNA.

Authors:  B Böddinghaus; T Rogall; T Flohr; H Blöcker; E C Böttger
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

6.  Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.

Authors:  S Leitzke; W Bucke; K Borner; R Müller; H Hahn; S Ehlers
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

7.  Disseminated "Mycobacterium genavense" infection in patients with AIDS.

Authors:  E C Böttger; A Teske; P Kirschner; S Bost; H R Chang; V Beer; B Hirschel
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

8.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients.

Authors:  M B Coyle; L C Carlson; C K Wallis; R B Leonard; V A Raisys; J O Kilburn; M Samadpour; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Mycobacterium genavense sp. nov.

Authors:  E C Böttger; B Hirschel; M B Coyle
Journal:  Int J Syst Bacteriol       Date:  1993-10
View more
  6 in total

1.  Formation of granulomas in the lungs of severe combined immunodeficient mice after infection with bacillus Calmette-Guerin.

Authors:  T Goldmann; G Zissel; R Sen Gupta; M Schlaak; E Vollmer; J Müller-Quernheim
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

2.  Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo.

Authors:  S Ehlers; E Richter
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor.

Authors:  Jessie Chen; MaiAnh Nguyen; Elaine Cheong; D Sean Riminton; Stephen Reddel
Journal:  BMJ Neurol Open       Date:  2022-05-18

Review 4.  Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.

Authors:  Blandine Rammaert; Louis-Jean Couderc; Elisabeth Rivaud; Patrick Honderlick; David Zucman; Marie-France Mamzer; Pierre Cahen; Emmanuel Bille; Marc Lecuit; Olivier Lortholary; Emilie Catherinot
Journal:  BMC Infect Dis       Date:  2011-11-05       Impact factor: 3.090

6.  Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.

Authors:  M Santos; A Gil-Brusola; A Escandell; M Blanes; M Gobernado
Journal:  Patholog Res Int       Date:  2014-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.